Recent availability of oral Wegovy adds another dimension to a market that now includes multiple FDA-approved medications in injectable and oral formats, off-label use of diabetes formulations, and compounded versions through telehealth platforms at various price points
For investors, this means the GLP-1 space isnt a trade on a single company anymore its an ecosystem, with value distributed across innovators, generic challengers, CDMO manufacturers, API suppliers, device makers, and the distribution infrastructure connecting all of them
Quan, W
doi: 10.4049/jimmunol.163.4.2209 120 HobbsJAMayRTanousisKMcNeillEMathiesMGebhardtCet al
Cost efficiency: Similar or lower cost for significantly better results
People taking the highest dose (12 mg) lost an average of 71 pounds over 16 months, starting from an average weight of about 249 pounds